Physician profile
Andrew Martin Swiergosz
NPI 1285167940
$14,225.14
in general payments reported to CMS, 2019-2025
20 companies · $2,847 in 2025
The $2,847 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.56 · 2021: $121 · 2022: $1,285 · 2023: $2,025 · 2024: $7,859 · 2025: $2,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,044 · Travel and Lodging: $4,426 · Education: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,044.28 |
| Travel and Lodging | $4,425.86 |
| Education | $261.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,461.65 | 2022-2025 | Mako, Makoplasty, Triathlon |
| Zimmer Biomet Holdings, INC. | $2,476.98 | 2023-2025 | Avenir, Persona, Rosa |
| Medical Device Business Services, INC. | $261.00 | 2023 | |
| Illuminoss Medical, INC. | $146.36 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Ferring Pharmaceuticals INC. | $120.90 | 2024-2025 | Euflexxa |
| Endo Pharmaceuticals INC. | $120.56 | 2021 | |
| Smith+Nephew, INC. | $94.88 | 2023-2025 | Pico 14, Pico 7, Renasys Touch |
| Medtronic USA, INC. | $88.56 | 2019 | |
| Melinta Therapeutics, LLC | $63.11 | 2023 | Orbactiv, Kimyrsa |
| Vertex Pharmaceuticals Incorporated | $61.13 | 2024-2025 | |
| Skeletal Dynamics INC | $60.71 | 2025 | Implate, Align, Geminus |
| Abbvie INC. | $51.03 | 2023-2025 | Dalvance |
| Depuy Synthes Sales INC. | $49.71 | 2024-2025 | Monovisc, Orthovisc, Na |
| Amgen INC. | $38.90 | 2023-2024 | Evenity, Prolia |
| Ethicon US, LLC | $33.80 | 2025 | Ethicon, Stratafix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $26.03 | 2023 | Zilretta, Iovera, Exparel |
| Davol INC. | $21.87 | 2025 | Channel Drain |
| Bioventus LLC | $19.66 | 2024 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $14.47 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Solventum Corporation | $13.83 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena, Prevena Restor Arthroform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Swiergosz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.